Bio-Techne Corp. (TECH) Financials

EPS

Hollow marker is the consensus estimate; filled is the reported figure, colored by beat or miss.

Revenue

Outlined bar is the consensus estimate; solid is reported.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
Q1 27	$0.52	$0.52	0.0%	—	—	—
Q4 26	$0.53	$0.53	0.0%	—	—	—
Q3 26	$0.43	$0.46	+7.0%	—	—	—
Q2 26	$0.42	$0.42	0.0%	—	—	—
Q1 26	$0.5	$0.53	+6.0%	—	—	—
Q4 25	$0.51	$0.56	+9.8%	—	—	—
Q3 25	$0.39	$0.42	+7.7%	—	—	—
Q2 25	$0.38	$0.42	+10.5%	—	—	—
Q1 25	$0.49	$0.49	0.0%	—	—	—
Q4 24	$0.46	$0.48	+4.3%	—	—	—
Q3 24	$0.41	$0.4	-2.4%	—	—	—
Q2 24	$0.44	$0.41	-6.8%	—	—	—
Q1 24	$0.55	$0.55	0.0%	—	—	—
Q4 23	$0.53	$0.53	0.0%	—	—	—
Q3 23	$0.49	$0.47	-4.1%	—	—	—
Q2 23	$0.46	$0.45	-2.2%	—	—	—

EPS

Reported per-share earnings by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Revenue

Reported revenue by fiscal year; the line turns dotted where reported figures end and the analyst consensus begins, with the shaded band marking the low–high range.

Results

Periods without a consensus estimate or a reported figure show a dash.

Period	EPS estimate	EPS actual	EPS surprise %	Revenue estimate	Revenue actual	Revenue surprise %
FY26	—	$1.17	—	—	$1.2B	—
FY25	—	$0.47	—	—	$1.2B	—
FY24	—	$1.07	—	—	$1.2B	—
FY23	—	$1.81	—	—	$1.1B	—

Total revenue

Reported revenue per period; the line is the change from the same period a year earlier, on its own left axis.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	$563M	$643M	$714M	$738.7M	$931M	$1.1B	$1.1B	$1.2B	$1.2B	$1.2B
YoY change	+12.8%	+14.2%	+11%	+3.46%	+26%	+18.7%	+2.81%	+1.97%	+5.23%	-0.38%

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Revenue	563M	643M	714M	738.7M	931M	1.1B	1.1B	1.2B	1.2B	1.2B
Cost of revenue	188.5M	210.8M	240.5M	255.5M	298.2M	349.1M	366.9M	389.3M	429.4M	416M
Gross profit	374.5M	432.1M	473.5M	483.2M	632.9M	756.5M	769.8M	769.7M	790.3M	799.1M
Gross margin	66.5%	67.2%	66.3%	65.4%	68%	68.4%	67.7%	66.4%	64.8%	65.8%
Research & development	53.5M	55.3M	62.4M	65.2M	70.6M	87.1M	92.5M	96.7M	99.5M	94.8M
Selling, general & administrative	153.3M	194.2M	236.9M	240.9M	289.9M	339M	352.4M	396.8M	415.1M	406.7M
Operating expenses	340.6M	409.4M	496.4M	306.1M	360.5M	426.1M	444.9M	493.5M	514.6M	501.4M
Operating income	144.6M	159.2M	147.1M	148.8M	242.7M	295.8M	291M	242.9M	242.8M	272.6M
Operating margin	25.7%	24.8%	20.6%	20.2%	26.1%	26.8%	25.6%	21%	19.9%	22.4%
Non-operating income, net	-25.5M	-23.4M	-14M	146.2M	-81M	16.1M	55.5M	-44.8M	-139.7M	-26.5M
Pretax income	112M	126M	112M	276.5M	148.2M	301.4M	338.7M	185.7M	98.5M	240.7M
Income tax	35.9M	-198K	15.9M	47.2M	8.6M	38.3M	53.2M	17.6M	25.1M	58.8M
Net income	76.1M	126.2M	96.1M	229.3M	139.6M	263.1M	285.4M	168.1M	73.4M	181.9M
Net margin	13.5%	19.6%	13.5%	31%	15%	23.8%	25.1%	14.5%	6.02%	15%
EBITDA	205.8M	225.2M	227M	232.5M	331.8M	399.2M	401M	351.4M	357.6M	376M
EPS	0.52	0.83	0.64	1.5	0.91	1.73	1.81	1.07	0.47	1.17
Diluted EPS	0.52	0.82	0.62	1.46	0.87	1.66	1.76	1.05	0.46	1.16

Revenue and profits

Revenue, gross profit, operating income, and net income per period.

Condensed income statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	276.9M	272.6M	303.4M	306.1M	289.5M	297M	316.2M	317M	286.6M	295.9M	311.4M	321.2M
Cost of revenue	91.7M	96M	98.8M	102.8M	106.4M	103.1M	101.6M	118.2M	98.4M	104.6M	103.1M	109.8M
Gross profit	185.2M	176.6M	204.6M	203.3M	183M	193.9M	214.6M	198.8M	188.1M	191.3M	208.3M	211.4M
Gross margin	66.9%	64.8%	67.4%	66.4%	63.2%	65.3%	67.9%	62.7%	65.6%	64.6%	66.9%	65.8%
Research & development	24M	22.9M	25.8M	24M	23.9M	25M	24.6M	26M	24.2M	23.1M	23.5M	23.9M
Selling, general & administrative	105.3M	115.7M	111.8M	64M	119.2M	121.5M	151.3M	23.2M	116.2M	113.7M	109.3M	67.4M
Operating expenses	129.3M	138.6M	137.6M	88M	143M	146.5M	175.8M	49.2M	140.5M	136.8M	132.8M	91.4M
Operating income	55.9M	38M	67M	82M	40M	47.4M	38.7M	116.7M	47.7M	54.5M	75.5M	95M
Operating margin	20.2%	13.9%	22.1%	26.8%	13.8%	16%	12.2%	36.8%	16.6%	18.4%	24.2%	29.6%
Non-operating income, net	-2.3M	-1.1M	-2.6M	-38.8M	1.4M	-3.7M	547K	-138M	2.3M	-2.4M	-2.8M	-23.6M
Pretax income	49.6M	33.4M	61.1M	41.7M	40.2M	42.9M	38.3M	-22.9M	48M	50.8M	71.2M	70.7M
Income tax	-1.4M	5.9M	12M	1.1M	6.6M	8M	15.7M	-5.2M	9.8M	12.8M	20.2M	16.1M
Net income	51M	27.5M	49.1M	40.6M	33.6M	34.9M	22.6M	-17.7M	38.2M	38M	51M	54.6M
Net margin	18.4%	10.1%	16.2%	13.3%	11.6%	11.7%	7.14%	-5.58%	13.3%	12.8%	16.4%	17%
EBITDA	82.7M	65.5M	92.4M	110.8M	70.5M	72.1M	67.9M	6.4M	75.3M	77.7M	97.8M	96.9M
EPS	0.32	0.17	0.31	0.26	0.21	0.22	0.14	-0.11	0.25	0.24	0.33	0.35
Diluted EPS	0.31	0.17	0.31	0.25	0.21	0.22	0.14	-0.11	0.24	0.24	0.32	0.35

P/E

Annual history by fiscal year; click a table row below to chart a different metric.

Current values are trailing twelve months where available, otherwise the latest fiscal year; unreported figures show a dash.

Key stats

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Market cap	4.4B	5.5B	7.9B	10.1B	17.4B	13.6B	12.8B	11.3B	8.1B	11B	11.4B
Enterprise value	4.6B	5.7B	8.2B	10.3B	17.6B	13.7B	13.1B	11.6B	8.4B	11B	11.4B
Shares outstanding	149.3M	149.9M	151.1M	152.8M	155M	156.9M	157.2M	157.7M	157.5M	156M	156M

Valuation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
P/E	57.6	44	82	44	125	51.7	44.9	67.2	110.4	60.6	62.5
P/S	7.79	8.62	11	13.7	18.7	12.3	11.3	9.75	6.64	9.07	9.36
P/B	4.62	5.14	6.76	7.3	11.1	7.99	6.52	5.46	4.22	5.23	5.37
EV/EBITDA	22.2	25.3	36.2	44.1	53.1	34.3	32.6	32.9	23.5	29.4	34.2
EV/Sales	8.12	8.87	11.5	13.9	18.9	12.4	11.5	9.98	6.88	9.09	9.39
Earnings yield	1.74%	2.28%	1.22%	2.27%	0.8%	1.94%	2.22%	1.49%	0.91%	1.65%	1.6%
FCF yield	2.93%	2.7%	1.98%	1.52%	1.76%	2.06%	1.68%	2.09%	3.17%	2.39%	2.02%
PEG	—	—	—	—	—	—	—	—	—	—	-0.15

Profitability

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Gross margin	66.5%	67.2%	66.3%	65.4%	68%	68.4%	67.7%	66.4%	64.8%	65.8%	65.8%
Operating margin	25.7%	24.8%	20.6%	20.2%	26.1%	26.8%	25.6%	21%	19.9%	22.4%	27.9%
Net margin	13.5%	19.6%	13.5%	31%	15%	23.8%	25.1%	14.5%	6.02%	15%	15%
ROE	8.01%	11.7%	8.24%	16.6%	8.88%	15.5%	14.5%	8.13%	3.83%	8.63%	9.03%
ROA	4.88%	7.92%	5.1%	11.3%	6.17%	11.5%	10.8%	6.22%	2.87%	7.03%	6.67%
ROIC	8.65%	12.9%	8.38%	8%	13%	14.5%	11.1%	9.42%	8.22%	9.66%	9.66%
Return on tangible assets	-15.1%	-25.5%	-13%	-49.6%	-21.3%	-63.8%	-162.1%	-65.8%	-54.3%	625.3%	625.3%

Financial health

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Current ratio	2.57	5.01	4.05	4.88	3.35	3.44	4.84	3.87	3.46	4.55	4.55
Quick ratio	2.12	3.93	3.15	3.92	2.59	2.64	3.5	2.75	2.38	3.35	3.35
Debt / equity	0.36	0.31	0.43	0.31	0.27	0.19	0.23	0.2	0.23	0.14	0.14
Debt / assets	0.22	0.21	0.27	0.21	0.19	0.14	0.17	0.16	0.17	0.11	0.11
Net debt / EBITDA	0.9	0.7	1.49	0.7	0.57	0.2	0.63	0.76	0.79	0.06	0.07
Interest coverage	16.2	13.4	6.16	15.4	11.6	27.7	31.2	12.8	12.6	26	26
Effective tax rate	32%	0%	14.2%	17.1%	5.8%	12.7%	15.7%	9.47%	25.5%	24.4%	24.4%

Per share

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Revenue per share	3.77	4.29	4.72	4.83	6.01	7.05	7.23	7.35	7.74	7.79	7.79
EPS (basic)	0.52	0.83	0.64	1.5	0.91	1.73	1.81	1.07	0.47	1.17	1.17
EPS (diluted)	0.52	0.82	0.62	1.46	0.87	1.66	1.76	1.05	0.46	1.16	1.16
Book value per share	6.36	7.2	7.71	9.04	10.1	10.8	12.5	13.1	12.2	13.5	13.5
FCF per share	0.86	1	1.03	1	1.99	1.79	1.38	1.5	1.63	1.69	1.68
Cash per share	1.06	1.21	1.1	1.77	1.49	1.57	1.3	0.97	1.03	1.7	1.69
Capex per share	0.1	0.14	0.17	0.34	0.29	0.29	0.24	0.4	—	—	—

Capital allocation

Metric	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26	Current
Capex / revenue	2.7%	3.26%	3.56%	7%	4.76%	4.06%	3.36%	5.42%	—	—	—
Capex / operating cash flow	10.5%	13.3%	14.6%	14.8%	17.6%	14.3%	11.4%	23.4%	—	—	—
Payout ratio	62.2%	38%	50.3%	21.3%	35.5%	19.1%	17.6%	30%	68.7%	27.4%	27.6%
Dividend yield	1.08%	0.87%	0.61%	0.48%	0.28%	0.37%	0.39%	0.45%	0.62%	0.45%	0.44%

Yield

0.44%

trailing twelve months

Frequency

Quarterly

Last dividend

$0.08

ex-dividend Aug 24, 2026

Payout ratio

28%

of earnings

Dividend growth

0 years

consecutive annual raises

Dividend per share

Split-adjusted payout per share by ex-dividend date.

Recent payouts

Ex-dividend	Amount
Aug 24, 2026	$0.08
May 18, 2026	$0.08
Feb 13, 2026	$0.08
Nov 17, 2025	$0.08
Aug 18, 2025	$0.08

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Revenue	$276.9M	$272.6M	$303.4M	$306.1M	$289.5M	$297M	$316.2M	$317M	$286.6M	$295.9M	$311.4M	$321.2M
YoY change	+2.7%	+0.37%	+3.16%	+1.59%	+4.52%	+8.96%	+4.2%	+3.55%	-1%	-0.39%	-1.51%	+1.33%

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Cash & short-term investments	157.7M	181.8M	166M	270.9M	231.6M	247M	204.3M	152.9M	162.2M	264.7M
Receivables	116.8M	120.3M	137.5M	122.5M	145.4M	194.5M	218.5M	241.4M	206.9M	216.6M
Inventory	60.2M	85.6M	91M	103.2M	116.7M	141.1M	171.6M	179.7M	189.4M	195.7M
Total current assets	348M	398.4M	412.6M	520.9M	510.6M	605.6M	621.5M	617.4M	608.3M	744.4M
Property, plant & equipment	-23.4M	-24.8M	-21M	63.9M	91.1M	59.2M	79.2M	98.6M	64.8M	39.5M
Goodwill & intangibles	2.1B	2.1B	2.6B	2.5B	2.9B	2.7B	2.8B	3B	2.7B	2.6B
Total assets	1.6B	1.6B	1.9B	2B	2.3B	2.3B	2.6B	2.7B	2.6B	2.6B
Accounts payable	16.9M	18.5M	16.2M	23.1M	29.4M	33.9M	25.7M	38M	25.3M	26.7M
Short-term debt	—	—	12.5M	22M	24.1M	24.4M	11.2M	12.9M	14.1M	14.9M
Total current liabilities	135.5M	79.5M	102M	106.7M	152.3M	176M	128.5M	159.4M	175.8M	163.7M
Long-term debt	343.8M	339M	492.7M	411.5M	396.5M	301.5M	443.8M	406.6M	430M	274.2M
Total liabilities	608.6M	514.1M	718.8M	646.4M	691.7M	593.8M	672.2M	635M	639.1M	478.5M
Shareholders' equity	949.6M	1.1B	1.2B	1.4B	1.6B	1.7B	2B	2.1B	1.9B	2.1B
Total debt	343.8M	339M	505.2M	433.5M	420.6M	326M	455M	419.5M	444.1M	289.1M
Net debt	252.2M	217M	404.3M	286.9M	221.5M	153.4M	274.4M	267.7M	281.9M	24.4M

Assets vs. liabilities & equity

What the company owns (left stack) against what it owes plus shareholders' equity (right stack). The two stacks should match — that's the balance.

Condensed balance sheet

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Cash & short-term investments	148.7M	135.7M	145.3M	152.9M	187.5M	177.5M	140.7M	162.2M	145M	172.9M	209.8M	264.7M
Receivables	204.6M	207.5M	227.9M	241.4M	223.7M	217.9M	237.1M	206.9M	183.9M	184.6M	214.6M	216.6M
Inventory	186.1M	180.8M	179.5M	179.7M	185M	188.4M	191.1M	189.4M	203.2M	205.4M	201.2M	195.7M
Total current assets	591.5M	590.6M	610.6M	617.4M	648.6M	634.6M	627.2M	608.3M	609.5M	637.4M	688M	744.4M
Property, plant & equipment	88.8M	91.4M	97.4M	98.6M	93M	85.9M	85.9M	64.8M	54.3M	44.6M	43.1M	39.5M
Goodwill & intangibles	3.1B	3.1B	3B	3B	2.9B	2.9B	2.8B	2.7B	2.7B	2.6B	2.6B	2.6B
Total assets	2.8B	2.7B	2.7B	2.7B	2.7B	2.7B	2.6B	2.6B	2.5B	2.5B	2.6B	2.6B
Accounts payable	28.1M	31.5M	28.9M	38M	31.6M	33.1M	31.6M	25.3M	30.2M	26.3M	23.5M	26.7M
Short-term debt	12.2M	12.7M	13M	12.9M	13.5M	13.5M	14M	14.1M	13.8M	13.7M	14.2M	14.9M
Total current liabilities	127.8M	135.2M	149.8M	159.4M	142.1M	161.3M	169.2M	175.8M	144.5M	140.4M	153.3M	163.7M
Long-term debt	537.3M	543M	481.8M	406.6M	385.4M	381.6M	409.4M	430M	380.7M	337.2M	276.1M	274.2M
Total liabilities	757.6M	767.2M	706.8M	635M	597.4M	591.9M	626.2M	639.1M	560.3M	511.7M	465.3M	478.5M
Shareholders' equity	2B	2B	2B	2.1B	2.1B	2.1B	2B	1.9B	2B	2B	2.1B	2.1B
Total debt	549.5M	555.7M	494.7M	419.5M	398.9M	395.1M	423.5M	444.1M	394.5M	350.9M	290.3M	289.1M
Net debt	400.9M	425.6M	354.8M	267.7M	211.4M	217.6M	282.8M	281.9M	249.5M	178M	80.5M	24.4M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	FY17	FY18	FY19	FY20	FY21	FY22	FY23	FY24	FY25	FY26
Net income	76.1M	126.2M	96.1M	229.3M	139.6M	263.1M	285.4M	168.1M	73.4M	181.9M
Depreciation & amortization	60M	64.5M	78.2M	82.7M	87.7M	101.1M	107.2M	111.7M	109.9M	97.4M
Stock-based compensation	14.6M	28.2M	32.3M	32.4M	49M	42.2M	39.2M	38M	40.8M	41.4M
Change in working capital	-14.7M	-11M	-22.5M	2M	-3.6M	-76.9M	-58.9M	-9M	10.5M	-15.8M
Operating cash flow	144.4M	157.9M	174.5M	350M	251.4M	313.7M	334.2M	269M	287.6M	292.1M
Capital expenditure	-15.2M	-20.9M	-25.4M	-51.7M	-44.3M	-44.9M	-38.2M	-62.9M	—	—
Investing cash flow	-306M	-38.7M	-336.8M	27.1M	-243.5M	-96.9M	-33.6M	-210M	-11.5M	4.6M
Dividends paid	-47.3M	-48M	-48.4M	-48.9M	-49.6M	-50.2M	-50.3M	-50.4M	-50.4M	-49.9M
Share repurchases	0	0	-15.4M	-50.1M	-43.2M	-160.9M	-19.6M	-80M	-275.7M	-41.7M
Financing cash flow	435.9M	-122.9M	262.9M	-403.3M	-127.6M	-405.5M	612.5M	-183.3M	-305.6M	-249.7M
Net change in cash	274.4M	-3.7M	100.6M	-26.2M	-119.7M	-188.7M	913M	-124.4M	-29.6M	47M
Free cash flow	128.5M	149.4M	156.2M	153.5M	307.9M	280.4M	216.1M	236.1M	256.6M	263.2M

Cash generation and uses

Cash from operations, what's left after capex, and what went back to shareholders. Bars below the line are cash going out.

Condensed cash flow statement

Click a row to chart it; unreported figures show a dash.

Period	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	Q3 26	Q4 26
Net income	51M	27.5M	49.1M	40.6M	33.6M	34.9M	22.6M	-17.7M	38.2M	38M	51M	54.6M
Depreciation & amortization	28.5M	27.8M	27.3M	28.1M	28.1M	27.1M	27.6M	27.1M	24.3M	24.7M	24.2M	24.1M
Stock-based compensation	10.1M	12.8M	8.1M	7.1M	10.2M	14.7M	11.4M	4.5M	11.7M	14M	10.5M	5.2M
Change in working capital	7.7M	8.4M	-21.2M	-3.9M	7.8M	1.4M	-24M	25.3M	6.3M	-7M	-35.7M	20.6M
Operating cash flow	84.9M	64.8M	56.7M	62.4M	75.8M	69.7M	32.5M	98.2M	27.6M	82.4M	86.7M	95.4M
Capital expenditure	-13.6M	-14.9M	-16.4M	-18M	-9.2M	-6.8M	-10.1M	—	—	—	—	—
Investing cash flow	-156.3M	-23.7M	-16.4M	-13.7M	-23.1M	-6.8M	-10.1M	658K	4.6M	0	0	0
Dividends paid	-12.7M	-12.6M	-12.6M	-12.6M	-12.7M	-12.7M	-12.6M	-12.4M	-12.4M	-12.5M	-12.5M	-12.5M
Share repurchases	0	-80M	0	0	—	—	-100M	-100.1M	-24K	0	0	-41.7M
Financing cash flow	57.1M	-151.7M	-70.7M	-83M	-36.7M	-13.7M	-120.9M	-162.7M	-67.7M	-53.7M	-72.7M	-55.6M
Net change in cash	-14.2M	-110.5M	-30.5M	-34.2M	16M	49.2M	-98.5M	-63.8M	-35.5M	28.7M	14M	39.8M
Free cash flow	45.8M	68.3M	64.5M	57.5M	54.7M	77.5M	31M	93.3M	22.2M	76.5M	77.6M	86.9M

Date	Ratio
Nov 30, 2022	4:1
Dec 4, 2000	2:1
Nov 18, 1997	2:1

Bio-Techne Corp. Financials

EPS

Revenue

Results

EPS

Revenue

Results

Total revenue

Total revenue

Revenue and profits

Condensed income statement

Revenue and profits

Condensed income statement

P/E

Key stats

Valuation

Profitability

Financial health

Per share

Capital allocation

Dividend per share

Recent payouts

Assets vs. liabilities & equity

Condensed balance sheet

Assets vs. liabilities & equity

Condensed balance sheet

Cash generation and uses

Condensed cash flow statement

Cash generation and uses

Condensed cash flow statement

Split history